| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YGYNO.2017.10.009 |
| P698 | PubMed publication ID | 29113722 |
| P50 | author | Ekaterina S. Jordanova | Q41602380 |
| Gatot Purwoto | Q79160403 | ||
| P2093 | author name string | Alexander A W Peters | |
| Gert J Fleuren | |||
| Vivian M Spaans | |||
| Marjolijn D Trietsch | |||
| Natalja Ter Haar | |||
| I Nyoman Bayu Mahendra | |||
| Michelle Osse | |||
| P2860 | cites work | The PI3K pathway as drug target in human cancer | Q24632283 |
| Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study | Q27276774 | ||
| Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline | Q28260063 | ||
| Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia | Q33200323 | ||
| Prevalence of human papillomavirus in Indonesia: a population-based study in three regions | Q33349978 | ||
| Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam | Q33378843 | ||
| A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes | Q33541323 | ||
| Landscape of genomic alterations in cervical carcinomas | Q34169464 | ||
| Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis | Q34569934 | ||
| Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers | Q35132338 | ||
| Chapter 5: Viral and host factors in human papillomavirus persistence and progression. | Q35154929 | ||
| Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome. | Q35702897 | ||
| Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers | Q35741587 | ||
| Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta | Q36165724 | ||
| Impact of human papilloma virus vaccination on adolescent knowledge, perception of sexual risk and need for safer sexual behaviors in Bali, Indonesia | Q36168769 | ||
| Somatic Variations in Cervical Cancers in Indian Patients | Q36187364 | ||
| Genetic profiles of cervical tumors by high-throughput sequencing for personalized medical care. | Q36201454 | ||
| Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway | Q36342871 | ||
| Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix | Q36412445 | ||
| PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials | Q36510935 | ||
| Somatic mutation in PIK3CA is a late event in cervical carcinogenesis | Q37082560 | ||
| Papillomaviruses in the causation of human cancers - a brief historical account | Q37365856 | ||
| Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix | Q37678092 | ||
| Integrated genomic and molecular characterization of cervical cancer | Q37706407 | ||
| Treatment of NRAS-mutant melanoma. | Q38386344 | ||
| Emerging strategies for targeting PI3K in gynecologic cancer | Q38598081 | ||
| Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review. | Q39033368 | ||
| FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression | Q39904718 | ||
| Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women | Q41519401 | ||
| Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells | Q43005361 | ||
| Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer | Q43596600 | ||
| Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix | Q43705732 | ||
| Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication | Q47860026 | ||
| Genetic alterations of PIK3CA and tumor response in patients with locally advanced cervical squamous cell carcinoma treated with cisplatin-based concurrent chemoradiotherapy. | Q53291150 | ||
| The Path to Cancer --Three Strikes and You're Out | Q86680630 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Indonesia | Q252 |
| P304 | page(s) | 189-196 | |
| P577 | publication date | 2017-11-04 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway | |
| P478 | volume | 148 |
| Q61807141 | MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous Carcinoma |
| Q55209571 | Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers. |
| Q95728096 | Pretreatment Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical Cancer |
Search more.